PE-Backed Patheon Closes Buy of Banner Pharmacaps

Mississauga, Ontario-based Patheon Inc., a provider of pharmaceuticals development and manufacturing services, closed its buy of Banner Pharmacaps Inc. for US$255 million. The High Point, North Carolina-based Banner Pharmacaps focuses on research, development and manufacturing of unique gelatin-based dosage forms. Patheon has since 2007 been a portfolio company of New York private equity firm JLL Partners.

17 December 2012•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles